Oxford (OXFD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Oxford Immunotec Reports First Quarter 2016 Financial Results
May 3, 2016 7:01 AM EDTFirst quarter revenue of $17.1 million, increased 24% compared to prior year periodOver 7 million cumulative tests sold through the end of the quarter
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 03, 2016 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced first quarter 2016 financial results.
We are very happy with our first quarter financial and operating results, said Dr. Peter Wrighton-Smith, Chief Executive Officer of Oxford Immunotec. "Our sales... More
